Review: Mitochondrial Dysfunction as a Proposed Bridge to Senescence and Inflammaging
This review proposes that dysfunctional mitochondria act as both initiators and amplifiers of cellular senescence and inflammation, contributing to tissue degeneration and age-related functional decline. [1]
Automatic summary · not editorially reviewed
The key findings
The review examines mitochondrial dysfunction as a mechanistic bridge linking bioenergetic failure to cellular senescence and inflammaging. [1]
The review emphasises a threshold effect of mitochondrial DNA mutations whose age-dependent clonal expansion can drive respiratory chain deficiency in vulnerable tissues. [1]
The authors state that the evidence supports a model in which dysfunctional mitochondria act as both initiators and amplifiers of senescence and inflammation. [1]
The source at a glance
- Study type / format
- Review article (abstract only)
- Population / context
- Not specified; the abstract discusses ageing biology, cells and tissues in general.
- Summary based on
- Study abstract
- Original publication
- October 9, 2026
Review links mitochondrial decline to senescence and inflammaging
The review describes ageing as a progressive decline in mitochondrial integrity that goes beyond impaired energy production. It also includes redox imbalance, defective quality control, altered organelle dynamics and persistent inflammatory signalling. The authors examine mitochondrial dysfunction as a mechanistic bridge linking bioenergetic failure to cellular senescence and inflammaging, which they call two central features of biological ageing.
Supporting source [1]
Proposed mechanisms: DNA damage, signalling and senescence
The review discusses how impaired oxidative phosphorylation, loss of mitochondrial membrane potential, increased electron leak and excessive reactive oxygen species damage mitochondrial DNA, proteins and lipids. This amplifies organelle dysfunction and compromises cellular homeostasis. It emphasises a threshold effect of mitochondrial DNA mutations, whose age-dependent clonal expansion can drive respiratory chain deficiency in vulnerable tissues. Mitochondria are also analysed as signalling platforms integrating regulated cell death and as sources of damage-associated molecular patterns promoting sterile inflammation. Mitochondrial dysfunction-associated senescence is highlighted as reshaping the senescence-associated secretory phenotype and reinforcing inflammaging.
Supporting source [1]
Abstract-only review: model, not tested intervention
The authors conclude that the evidence supports a model in which dysfunctional mitochondria act as both initiators and amplifiers of senescence and inflammation. They suggest that understanding these interconnected mechanisms may help identify therapeutic strategies targeting mitochondrial bioenergetics, inflammatory signalling and senescent cell burden. This is a review abstract; it reports no study design, sample, follow-up or measured outcomes, and the full text was not reviewed. The proposed therapeutic directions are not tested treatments.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. This is a review proposing a mechanistic model, not a primary study with design, sample, follow-up or measured outcomes. Proposed therapeutic strategies are not tested treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Nesci S, Algieri C. · europepmc.org · October 9, 2026